AGPU
Axe Compute Inc.
Company overview
- Market capitalization
- $140.83M
- Employees
- 13
- Latest publication
- 2026-09-29
About Axe Compute Inc.
Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services. The Compute Services and Treasury Management segment provides access to graphics processing unit compute capacity and digital asset treasury strategy focused on Aethir token. The Drug Discovery Services segment engages in the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,214,992USD | 35,311USD | 8,674USD | 3,618USD | 2,682USD | 110,310USD | 611,585USD | 345,686USD |
| Cost Of Revenue | 7,417,650USD | 186,292USD | 927USD | 8,356USD | 18,221USD | 45,118USD | 290,626USD | 196,919USD |
| Gross Profit | -4,202,658USD | -150,981USD | 7,747USD | -4,738USD | -15,539USD | 65,192USD | 320,959USD | 148,767USD |
| Selling General Administrative | 2,735,922USD | 2,905,122USD | 19,607,428USD | 2,613,075USD | 1,875,655USD | 1,828,200USD | 1,585,109USD | 1,582,671USD |
| Selling And Marketing Expenses | 1,176,162USD | 8,387USD | 161USD | 133,494USD | 268,959USD | 3,633USD | 197,389USD | 246,650USD |
| General And Administrative Expenses | 2,735,922USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 13,125,352USD | 3,281,432USD | 20,206,133USD | 3,275,126USD | 2,644,329USD | 2,352,239USD | 2,444,607USD | 2,462,743USD |
| Operating Income | -17,328,010USD | -3,432,413USD | -20,198,386USD | -3,279,864USD | -2,659,868USD | -2,287,047USD | -2,123,648USD | -2,313,976USD |
| Discontinued Operations | 0USD | — | — | — | — | — | — | — |
| Net Income | -17,205,882USD | -7,708,943USD | -150,930,025USD | -77,651,843USD | -2,070,462USD | -2,442,873USD | -2,169,594USD | -3,094,690USD |
| Net Income Applicable To Common Shares | -17,205,882USD | — | — | — | — | — | — | — |
| Research Development | — | 547,445USD | 598,544USD | 528,557USD | 499,715USD | 520,406USD | 25,987USD | 535,236USD |
| Income Before Tax | — | -7,708,943USD | -150,942,599USD | -77,646,737USD | -1,978,895USD | -2,285,416USD | -2,100,862USD | -2,283,413USD |
| Net Income From Continuing Ops | — | -7,708,943USD | -150,942,599USD | -77,646,737USD | -1,978,895USD | -2,285,416USD | -2,100,862USD | -2,129,880USD |
| Ebit | — | -3,432,413USD | -20,198,386USD | -77,646,737USD | -1,978,898USD | -2,287,047USD | -2,123,648USD | -2,313,976USD |
| Ebitda | — | -3,252,891USD | -20,020,725USD | -77,614,125USD | -1,808,643USD | -2,120,981USD | -1,550,004USD | -2,273,303USD |
| Depreciation And Amortization | — | 179,522USD | 177,661USD | 32,612USD | 170,255USD | 166,066USD | 573,644USD | 40,673USD |
| Reconciled Depreciation | — | 179,522USD | 177,661USD | 174,594USD | 170,255USD | 166,066USD | 573,644USD | 158,188USD |
| Total Other Income Expense Net | — | -4,276,530USD | -130,744,213USD | -74,366,873USD | 680,973USD | 1,631USD | 22,786USD | 30,563USD |
| Income Tax Expense | — | — | 406,481USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 125,284USD | 1,623,817USD | 1,627,697USD | 1,505,459USD | 1,420,680USD | 1,252,272USD | 1,411,565USD | 1,411,655USD |
| Cost Of Revenue | 72,622USD | 826,137USD | 609,212USD | 505,107USD | 487,024USD | 447,192USD | 531,810USD | 415,764USD |
| Gross Profit | 52,662USD | 797,680USD | 1,018,485USD | 1,000,352USD | 933,656USD | 805,080USD | 879,755USD | 995,891USD |
| Research Development | 2,147,222USD | 25,987USD | 122,307USD | 320,320USD | 315,850USD | 372,710USD | 2,960,131USD | 526,257USD |
| Selling General Administrative | 25,924,358USD | 7,419,892USD | 7,569,827USD | 11,110,735USD | 10,932,125USD | 10,351,973USD | 9,781,218USD | 4,626,997USD |
| Selling And Marketing Expenses | 406,247USD | 1,466,213USD | 1,487,139USD | 1,358,907USD | 774,530USD | 584,937USD | 1,912,899USD | 2,369,152USD |
| Total Operating Expenses | 28,477,827USD | 11,737,150USD | 13,136,221USD | 27,034,004USD | 21,362,287USD | 26,165,117USD | 23,524,498USD | 8,857,270USD |
| Operating Income | -28,425,165USD | -10,939,470USD | -12,117,736USD | -26,033,652USD | -20,428,631USD | -25,360,037USD | -22,644,743USD | -7,861,379USD |
| Income Before Tax | -232,853,647USD | -10,860,205USD | -12,017,561USD | -25,737,634USD | -20,318,832USD | -25,884,397USD | -19,390,766USD | -10,086,477USD |
| Net Income | -233,095,203USD | -12,201,261USD | -13,983,967USD | -25,737,634USD | -19,657,174USD | -25,884,397USD | -19,390,766USD | -10,086,477USD |
| Net Income From Continuing Ops | -232,853,647USD | -10,860,205USD | -12,017,561USD | -25,737,634USD | -19,657,174USD | — | — | — |
| Ebit | -28,425,165USD | -10,939,470USD | -12,117,736USD | -15,267,715USD | -13,471,564USD | -12,483,539USD | -13,774,493USD | -7,861,379USD |
| Ebitda | -27,736,589USD | -10,243,807USD | -11,872,948USD | -13,954,640USD | -12,131,263USD | -11,458,691USD | -13,069,610USD | -7,713,751USD |
| Depreciation And Amortization | 688,576USD | 695,663USD | 244,788USD | 1,313,075USD | 1,340,301USD | 1,024,848USD | 704,883USD | 147,628USD |
| Reconciled Depreciation | 688,576USD | 695,663USD | 724,808USD | 1,313,075USD | 1,340,301USD | — | — | — |
| Total Other Income Expense Net | -204,428,482USD | 79,265USD | 100,175USD | 296,018USD | 109,799USD | -524,360USD | 3,253,977USD | -2,225,098USD |
| Unclassified Operating Expenses | — | 2,825,058USD | 3,956,948USD | 14,244,042USD | 9,339,782USD | 14,855,497USD | 8,870,250USD | 1,334,864USD |
| Interest Expense | — | — | — | 10,650,290USD | — | — | — | — |
| Tax Provision | — | — | — | 0USD | -661,658USD | — | — | — |
| Income Tax Expense | — | — | — | — | -661,658USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 100,375,956USD | 45,222,576USD | 52,888,346USD | 3,137,298USD | 3,435,366USD | 5,868,251USD | 4,972,517USD | 7,498,234USD |
| Cash And Equivalents | 21,905,767USD | — | — | — | — | — | — | — |
| Total Current Assets | 56,065,160USD | 37,592,359USD | 42,769,947USD | 1,103,951USD | 1,223,394USD | 3,486,024USD | 2,225,918USD | 4,567,408USD |
| Other Current Assets | 873,423USD | 20,571,200USD | 31,946,977USD | 858,286USD | 651,653USD | 292,848USD | 359,951USD | 520,239USD |
| Other Non Current Assets | 146,598USD | — | — | — | — | — | — | — |
| Total Liabilities | 66,330,761USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 38,686,908USD | 4,227,281USD | 4,266,896USD | 79,488,676USD | 3,845,439USD | 4,609,043USD | 3,593,401USD | 3,816,766USD |
| Other Current Liabilities | 1,425,113USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 34,045,195USD | 40,270,760USD | 47,716,955USD | -77,427,922USD | -1,653,400USD | -145,796USD | -202,610USD | 1,966,969USD |
| Total Equity Including Noncontrolling Interest | 34,045,195USD | — | — | — | — | — | — | — |
| Deferred Revenue | 33,645,987USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 27,108,685USD | — | — | — | — | — | — | — |
| Net Receivables | 3,321,426USD | 10,095,915USD | 32,120USD | 26,009USD | 22,957USD | 59,828USD | 745,566USD | 463,834USD |
| Property Plant Equipment Net | 18,472,433USD | 1,553,453USD | 1,710,831USD | 1,887,347USD | 2,060,796USD | 2,229,907USD | 2,433,977USD | 2,606,844USD |
| Accounts Payable | 2,494,038USD | 1,345,926USD | 1,840,608USD | 2,717,725USD | 1,346,499USD | 1,214,349USD | 1,142,919USD | 1,141,922USD |
| Short Term Debt | 708,159USD | 707,680USD | 761,694USD | 815,283USD | 868,366USD | 513,280USD | 572,739USD | 692,564USD |
| Common Stock | 113,849USD | 55,393USD | 40,832USD | 7,671USD | 95,967USD | 89,316USD | 66,670USD | 66,670USD |
| Retained Earnings | -438,436,299USD | -421,230,417USD | -413,521,474USD | -262,591,449USD | -184,939,606USD | -182,869,144USD | -180,426,271USD | -178,256,677USD |
| Total Liab | — | 4,951,816USD | 5,171,391USD | 80,565,220USD | 5,088,766USD | 6,014,047USD | 5,175,127USD | 5,531,265USD |
| Other Current Liab | — | 1,387,359USD | 1,664,594USD | 75,955,668USD | 1,481,498USD | 2,729,838USD | 1,572,758USD | 1,982,280USD |
| Capital Stock | — | 56,185USD | 41,624USD | 8,463USD | 96,759USD | 90,108USD | 67,462USD | 67,462USD |
| Other Assets | — | 1USD | — | — | — | — | — | — |
| Cash | — | 6,925,244USD | 10,790,850USD | 181,667USD | 506,078USD | 3,087,588USD | 734,673USD | 3,078,955USD |
| Cash And Short Term Investments | — | 6,925,244USD | 10,790,850USD | 181,667USD | 506,078USD | 3,087,588USD | 734,673USD | 3,078,955USD |
| Current Deferred Revenue | — | 786,316USD | — | — | 149,076USD | 151,576USD | 304,985USD | — |
| Net Debt | — | -5,493,029USD | -9,124,661USD | 1,710,160USD | 1,605,615USD | -1,169,304USD | 1,396,305USD | -681,938USD |
| Short Long Term Debt | — | 27,210USD | 107,951USD | 187,374USD | 265,501USD | — | — | 195,776USD |
| Short Long Term Debt Total | — | 1,432,215USD | 1,666,189USD | 1,891,827USD | 2,111,693USD | 1,918,284USD | 2,130,978USD | 2,397,017USD |
| Property Plant Equipment Gross | — | 3,387,024USD | 3,517,130USD | 3,663,587USD | 3,805,569USD | 3,943,213USD | 4,472,741USD | 4,834,085USD |
| Common Stock Shares Outstanding | — | 21,184,617shares | 17,429,861shares | 723,998shares | 9,108,990shares | 7,152,225shares | 5,453,625shares | 6,396,225shares |
| Non Current Assets Total | — | 7,630,216USD | 10,118,399USD | 2,033,347USD | 2,211,972USD | 2,382,227USD | 2,746,599USD | 2,930,826USD |
| Non Current Liabilities Total | — | 724,535USD | 904,495USD | 1,076,544USD | 1,243,327USD | 1,405,004USD | 1,581,726USD | 1,714,499USD |
| Non Currrent Assets Other | — | 147,741USD | 8,407,568USD | 98,478USD | 102,509USD | 102,509USD | 102,509USD | 102,509USD |
| Net Working Capital | — | 33,365,078USD | 38,503,051USD | -78,384,725USD | -2,622,045USD | -1,123,019USD | -1,367,483USD | 750,642USD |
| Unclassified Non Current Assets | — | 5,929,021USD | — | — | — | — | — | — |
| Unclassified Equity | — | 461,389,599USD | 461,155,973USD | 185,147,393USD | 183,093,480USD | 182,543,924USD | 180,089,529USD | 180,089,514USD |
| Intangible Assets | — | — | — | 47,522USD | 48,667USD | 49,811USD | 210,113USD | 221,473USD |
| Inventory | — | — | — | 37,989USD | 42,706USD | 45,760USD | 385,728USD | 504,380USD |
| Unclassified Non Current Liabilities | — | — | — | 1,076,544USD | 1,243,327USD | 1,405,004USD | 1,558,239USD | 1,704,453USD |
| Non Current Liabilities Other | — | — | — | — | — | — | 23,487USD | 10,046USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 52,888,346USD | 4,972,517USD | 14,417,249USD | 25,734,644USD | 43,771,271USD | 13,060,436USD | 22,375,510USD | 3,709,000USD |
| Other Current Assets | 31,946,977USD | 359,951USD | 591,327USD | 526,801USD | 513,778USD | 289,490USD | 160,222USD | 318,431USD |
| Total Liab | 5,171,391USD | 5,175,127USD | 6,145,469USD | 3,968,752USD | 3,505,587USD | 10,417,755USD | 11,144,192USD | 3,655,527USD |
| Total Stockholder Equity | 47,716,955USD | -202,610USD | 8,271,780USD | 21,765,892USD | 40,265,684USD | 2,642,681USD | 11,231,318USD | 53,472USD |
| Other Current Liab | 1,664,594USD | 1,572,758USD | 1,719,163USD | 2,242,908USD | 1,392,121USD | 2,882,429USD | 1,963,141USD | 1,551,859USD |
| Common Stock | 40,832USD | 66,670USD | 40,629USD | 39,382USD | 656,146USD | 198,048USD | 40,567USD | 14,092USD |
| Capital Stock | 41,624USD | 67,462USD | 41,421USD | 40,174USD | 656,938USD | — | — | — |
| Retained Earnings | -413,521,474USD | -180,426,271USD | -167,761,883USD | -153,777,916USD | -128,040,282USD | -108,383,108USD | -82,498,711USD | -63,107,945USD |
| Cash | 10,790,850USD | 734,673USD | 8,728,660USD | 22,071,523USD | 28,202,615USD | 678,332USD | 150,831USD | 162,152USD |
| Cash And Short Term Investments | 10,790,850USD | 734,673USD | 8,728,660USD | 22,071,523USD | 28,202,615USD | 678,332USD | 150,831USD | 162,152USD |
| Total Current Assets | 42,769,947USD | 2,225,918USD | 10,078,431USD | 23,360,013USD | 29,458,273USD | 1,514,235USD | 798,264USD | 1,451,527USD |
| Total Current Liabilities | 4,266,896USD | 3,593,401USD | 3,951,031USD | 3,882,670USD | 3,240,508USD | 9,336,921USD | 10,873,928USD | 3,655,527USD |
| Net Debt | -9,124,661USD | 1,396,305USD | -6,002,378USD | -21,891,204USD | -27,323,289USD | 5,196,191USD | 5,834,195USD | 1,472,762USD |
| Short Term Debt | 761,694USD | 572,739USD | 595,305USD | 94,237USD | 639,662USD | 5,029,394USD | 5,714,762USD | 1,634,914USD |
| Short Long Term Debt | 107,951USD | — | 150,408USD | — | — | — | — | — |
| Short Long Term Debt Total | 1,666,189USD | 2,130,978USD | 2,726,282USD | 180,319USD | 879,326USD | 5,874,523USD | 5,985,026USD | 1,634,914USD |
| Net Receivables | 32,120USD | 745,566USD | 277,641USD | 331,196USD | 354,196USD | 256,878USD | 297,055USD | 729,878USD |
| Accounts Payable | 1,840,608USD | 1,142,919USD | 1,334,064USD | 943,452USD | 1,021,774USD | 1,372,070USD | 3,155,641USD | 445,689USD |
| Property Plant Equipment Net | 1,710,831USD | 2,433,977USD | 3,962,265USD | 2,045,148USD | 3,326,025USD | 5,218,051USD | 2,237,544USD | 180,453USD |
| Property Plant Equipment Gross | 3,517,130USD | 4,472,741USD | 5,234,037USD | 4,922,748USD | 5,394,363USD | — | — | — |
| Common Stock Shares Outstanding | 17,429,861shares | 5,453,625shares | 4,014,840shares | 3,685,950shares | 2,743,800shares | 597,510shares | 143,505shares | 64,080shares |
| Non Current Assets Total | 10,118,399USD | 2,746,599USD | 4,338,818USD | 2,374,631USD | 14,312,997USD | 11,546,201USD | 21,577,246USD | 2,257,472USD |
| Non Current Liabilities Total | 904,495USD | 1,581,726USD | 2,194,438USD | 86,082USD | 265,079USD | 1,080,834USD | 270,264USD | — |
| Non Currrent Assets Other | 8,407,568USD | 102,509USD | 124,096USD | 75,618USD | 167,065USD | 116,257USD | — | 1,112,524USD |
| Net Working Capital | 38,503,051USD | -1,367,483USD | 6,127,400USD | 19,477,343USD | 26,217,765USD | — | — | — |
| Unclassified Equity | 461,155,973USD | 180,089,529USD | 175,951,613USD | 175,464,252USD | 166,992,882USD | 110,827,741USD | 93,689,462USD | 63,147,325USD |
| Intangible Assets | — | 210,113USD | 252,457USD | 253,865USD | 3,962,117USD | 3,398,101USD | 3,649,412USD | 964,495USD |
| Current Deferred Revenue | — | 304,985USD | 302,499USD | 602,073USD | 186,951USD | 53,028USD | 40,384USD | 23,065USD |
| Inventory | — | 385,728USD | 480,803USD | 430,493USD | 387,684USD | 289,535USD | 190,156USD | 241,066USD |
| Non Current Liabilities Other | — | 23,487USD | 5,459USD | — | 25,415USD | — | — | — |
| Unclassified Non Current Liabilities | — | 1,558,239USD | 2,188,979USD | — | — | 1,080,834USD | — | — |
| Good Will | — | — | — | 0USD | 6,857,790USD | 2,813,792USD | 15,690,290USD | — |
| Other Assets | — | — | — | — | 1USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 54,650USD |
| Stock Based Compensation | 682,942USD |
| Change To Account Receivables | -3,289,306USD |
| Change To Inventory | 0USD |
| Change To Liabilities | 558,024USD |
| Change In Working Capital | -3,228,395USD |
| Operating Cash Flow | 17,370,239USD |
| Capital Expenditures | -17,121,106USD |
| Investing Cash Flow | -17,121,106USD |
| Net Common Stock Issuance | -74,121USD |
| Change In Cash | 11,114,917USD |
| End Cash Flow | 21,905,767USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,708,943USD | -150,772,568USD | -77,646,737USD | -1,978,895USD | -2,285,416USD | -2,100,862USD | -2,283,413USD | -3,181,261USD |
| Depreciation | 179,522USD | 177,661USD | 174,593USD | 170,255USD | 166,066USD | 40,060USD | 39,796USD | 164,165USD |
| Stock Based Compensation | 111,358USD | — | — | — | 0USD | — | — | — |
| Other Non Cash Items | 4,328,270USD | 146,901,289USD | 74,870,811USD | -639,061USD | 229,494USD | 1,292,684USD | -1,968,705USD | 119,405USD |
| Change To Account Receivables | -627,205USD | -6,111USD | -3,052USD | 36,871USD | -25,674USD | -281,732USD | -132,850USD | 122,405USD |
| Change In Working Capital | -656,630USD | -47,480USD | 947,610USD | -876,141USD | 1,133,510USD | -2,273,964USD | 1,039,230USD | -320,360USD |
| Total Cash From Operating Activities | -3,746,423USD | -3,741,098USD | -1,653,723USD | -3,323,842USD | -756,346USD | -3,042,082USD | -3,173,092USD | -3,218,051USD |
| Capital Expenditures | -21,000USD | 0USD | -3USD | -2USD | -4USD | -2USD | -3USD | -6,478USD |
| Free Cash Flow | -3,767,423USD | -3,741,098USD | -1,653,720USD | -3,323,840USD | -756,350USD | -3,042,080USD | -3,173,090USD | -3,224,529USD |
| Total Cashflows From Investing Activities | -21,000USD | -33,241,819USD | — | — | 625,000USD | 32,000USD | 32,000USD | -6,478USD |
| Net Borrowings | -80,741USD | -79,423USD | -76,674USD | 264,048USD | 0USD | -195,776USD | -79,322USD | — |
| Total Cash From Financing Activities | -98,183USD | 47,450,668USD | 1,329,312USD | 726,906USD | 2,499,687USD | -195,776USD | 888,278USD | 3,359,064USD |
| Issuance Of Capital Stock | 14,193USD | 51,396,577USD | 1,444,044USD | 585,979USD | 2,579,386USD | 0USD | 1,264,714USD | — |
| Change In Cash | -3,865,606USD | 10,467,751USD | -324,411USD | -2,581,510USD | 2,352,915USD | -2,344,282USD | -2,252,815USD | 134,535USD |
| Begin Period Cash Flow | 10,790,850USD | 181,667USD | 506,078USD | 3,087,588USD | 734,673USD | 3,078,955USD | 5,331,770USD | 5,197,235USD |
| End Period Cash Flow | 6,925,244USD | 10,649,418USD | 181,667USD | 506,078USD | 3,087,588USD | 734,673USD | 3,078,955USD | 5,331,770USD |
| Other Cashflows From Financing Activities | -17,443USD | -3,866,486USD | — | — | — | 1,264,714USD | — | — |
| Change To Inventory | — | -7,771USD | 4,717USD | 3,054USD | 0USD | 118,652USD | 50,264USD | -126,497USD |
| Other Cashflows From Investing Activities | — | -96,215,801USD | — | — | 625,000USD | 32,000USD | 38,478USD | — |
| Unclassified Investing Cash Flow | — | 62,973,982USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | -1,264,714USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -233,095,203USD | -10,860,205USD | -12,017,561USD | -25,737,634USD | -19,657,174USD | -25,884,397USD | -19,390,766USD | -10,086,477USD |
| Depreciation | 688,576USD | 695,663USD | 724,808USD | 1,313,075USD | 1,340,301USD | 1,024,848USD | 704,883USD | 147,628USD |
| Other Non Cash Items | 221,290,551USD | -876,567USD | -1,116,278USD | 11,187,073USD | 7,042,853USD | 13,814,693USD | 8,079,980USD | 2,306,428USD |
| Change To Account Receivables | 2,034USD | -467,925USD | 19,003USD | 23,000USD | -20,769USD | 69,913USD | 143,316USD | -95,103USD |
| Change In Working Capital | 1,157,499USD | -914,562USD | -780,360USD | 866,686USD | -1,194,382USD | -1,212,876USD | 1,873,452USD | 884,299USD |
| Total Cash From Operating Activities | -9,958,577USD | -11,955,671USD | -13,189,391USD | -12,370,800USD | -12,208,929USD | -12,257,732USD | -8,732,451USD | -5,287,956USD |
| Capital Expenditures | -32,616,819USD | -9,509USD | -21,529USD | -475,697USD | -962,322USD | -360,777USD | -26,607USD | -232,003USD |
| Free Cash Flow | -42,492,858USD | -11,965,180USD | -13,210,920USD | -12,846,497USD | -13,171,251USD | -12,618,509USD | -8,759,058USD | -5,519,959USD |
| Total Cashflows From Investing Activities | -31,991,819USD | 22,490USD | -302,371USD | -475,697USD | -10,607,536USD | -167,456USD | -599,087USD | -1,110,651USD |
| Net Borrowings | 107,951USD | -150,408USD | 150,408USD | 0USD | -4,162,744USD | — | — | — |
| Total Cash From Financing Activities | 52,006,573USD | 3,939,194USD | 148,898USD | 6,715,405USD | 50,340,748USD | 12,952,689USD | 9,320,217USD | 5,794,570USD |
| Issuance Of Capital Stock | 56,005,986USD | 4,960,562USD | 0USD | 6,743,059USD | 51,199,117USD | — | — | — |
| Change In Cash | 10,056,177USD | -7,993,987USD | -13,342,863USD | -6,131,092USD | 27,524,283USD | 527,501USD | -11,321USD | -604,037USD |
| Begin Period Cash Flow | 734,673USD | 8,728,660USD | 22,071,523USD | 28,202,615USD | 678,332USD | 150,831USD | 162,152USD | 766,189USD |
| End Period Cash Flow | 10,790,850USD | 734,673USD | 8,728,660USD | 22,071,523USD | 28,202,615USD | 678,332USD | 150,831USD | 162,152USD |
| Other Cashflows From Investing Activities | -62,348,982USD | 32,000USD | -254,821USD | — | -55,000USD | — | -841,301USD | -1,123,619USD |
| Other Cashflows From Financing Activities | -4,107,364USD | — | 794USD | — | 4,389,371USD | 1,713,944USD | 2,142,516USD | 650,061USD |
| Unclassified Investing Cash Flow | 62,973,982USD | — | — | — | -9,590,214USD | — | — | — |
| Change To Inventory | — | 95,075USD | -65,448USD | -42,808USD | -98,149USD | -94,715USD | 91,114USD | 23,979USD |
| Sale Purchase Of Stock | — | 0USD | -1,510USD | -27,654USD | -11,526USD | — | — | — |
| Unclassified Financing Cash Flow | — | 4,089,602USD | — | 6,743,059USD | 50,125,647USD | 11,238,745USD | 7,177,701USD | 5,144,509USD |
| Dividends Paid | — | — | -794USD | — | — | — | — | — |
| Stock Based Compensation | — | — | — | 522,437USD | 921,131USD | 1,172,170USD | — | 1,460,166USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | -1,172,170USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Segment | Compute Services And Treasury Management | 6,935 | USD | 0001171843-26-003484 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Drug Discovery Services | 28,376 | USD | 0001171843-26-003484 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Compute Services And Treasury Management | 0 | USD | 0001171843-26-003484 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Drug Discovery Services | 110,310 | USD | 0001171843-26-003484 |
| FY 2024Yearly · 2024-12-31 | Segment | Compute Services And Treasury Management | 0 | USD | 0001171843-26-002094 |
| FY 2024Yearly · 2024-12-31 | Segment | Drug Discovery Services | 84,812 | USD | 0001171843-26-002094 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Eagan | 341,779 | USD | 0001171843-24-006292 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Pittsburgh | 3,907 | USD | 0001171843-24-006292 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Birmingham | 20,813 | USD | 0001171843-24-004757 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Eagan | 190,654 | USD | 0001171843-24-004757 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Pittsburgh | 67,255 | USD | 0001171843-24-004757 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Birmingham | 11,009 | USD | 0001171843-24-002875 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Eagan | 403,779 | USD | 0001171843-24-002875 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Pittsburgh | 4,858 | USD | 0001171843-24-002875 |
| Q4 2023Quarterly · 2023-12-31 | Segment | Birmingham | 15,437 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | Eagan | 268,566 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | Pittsburgh | 51,029 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Segment | Eagan | 1,135,101 | USD | 0001171843-25-001863 |
| FY 2023Yearly · 2023-12-31 | Segment | Pittsburgh | 492,596 | USD | 0001171843-25-001863 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Eagan | 259,530 | USD | 0001171843-24-006292 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Pittsburgh | 417,096 | USD | 0001171843-24-006292 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Birmingham | 84,880 | USD | 0001171843-24-004757 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Eagan | 391,386 | USD | 0001171843-24-004757 |
| Q2 2023Quarterly · 2023-06-30 | Segment | Pittsburgh | 13,844 | USD | 0001171843-24-004757 |
| FY 2022Yearly · 2022-12-31 | Segment | Helomics | 6,397 | USD | 0001171843-23-001805 |
| FY 2022Yearly · 2022-12-31 | Segment | Skyline | 1,063,493 | USD | 0001171843-23-001805 |
| FY 2022Yearly · 2022-12-31 | Segment | Soluble | 82,301 | USD | 0001171843-23-001805 |
| FY 2022Yearly · 2022-12-31 | Segment | ZPREDICTA | 352,379 | USD | 0001171843-23-001805 |
| FY 2021Yearly · 2021-12-31 | Segment | Helomics | 13,367 | USD | 0001171843-23-001805 |
| FY 2021Yearly · 2021-12-31 | Segment | Other | 4,119 | USD | 0001171843-23-001805 |
| FY 2021Yearly · 2021-12-31 | Segment | Skyline | 1,169,811 | USD | 0001171843-23-001805 |
| FY 2021Yearly · 2021-12-31 | Segment | Soluble | 233,293 | USD | 0001171843-23-001805 |
| FY 2021Yearly · 2021-12-31 | Segment | ZPREDICTA | 90 | USD | 0001171843-23-001805 |
| FY 2020Yearly · 2020-12-31 | Segment | Helomics | 64,188 | USD | 0001171843-22-002237 |
| FY 2020Yearly · 2020-12-31 | Segment | Skyline | 1,185,214 | USD | 0001171843-22-002237 |
| FY 2020Yearly · 2020-12-31 | Segment | Soluble | 2,870 | USD | 0001171843-22-002237 |
| FY 2019Yearly · 2019-12-31 | Segment | Domestic | 1,275,048 | USD | 0001171843-20-002217 |
| FY 2019Yearly · 2019-12-31 | Segment | Helomics | 48,447 | USD | 0001171843-20-002217 |
| FY 2019Yearly · 2019-12-31 | Segment | International | 88,070 | USD | 0001171843-20-002217 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.